
After the Storm: Why MDMA Assisted Therapy Still Matters
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Acerca de esta escucha
Dr. Chantelle Thomas and Dr. Evan Sola discuss the implications of the FDA's decision not to approve MDMA for PTSD treatment, emphasizing the nuances of the MDMA-assisted therapy model. They highlight ongoing clinical trials, including those at the Portland VA and UCLA, and the importance of accurate public and therapist education. Dr. Sola shares his experience with severe PTSD patients and the relational aspects of therapy, stressing the need for humility and supervision. They address misconceptions about the model, advocating for a non-pathologizing, participant-led approach that values the therapist's role in validating and supporting the client's process.
(0:00:33) Introduction
(0:07:30) Evan Sola and His Work
(0:18:13) Discussion on Public Perception and Therapist Education
(0:29:37) Challenges and Misrepresentations of the MDMA-Assisted Therapy Model
(1:11:45) The Importance of Relationality and Organicity in Therapy
Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/
Frontier article:
https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2024.1427531/full
Integrata: www.integratahealing.com
Evan Sola, PSYD: https://www.evansolapsyd.com/
Lykos: https://lykospbc.com